Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
9.02%
operating margin TTM
13.19%
revenue TTM
16.46 Billion
revenue per share TTM
14.14$
valuation ratios | |
|---|---|
| pe ratio | 25.67 |
| peg ratio | 0.01 |
| price to book ratio | 4.88 |
| price to sales ratio | 2.33 |
| enterprise value multiple | 8.34 |
| price fair value | 4.88 |
profitability ratios | |
|---|---|
| gross profit margin | 52.08% |
| operating profit margin | 13.19% |
| pretax profit margin | 7.95% |
| net profit margin | 9.02% |
| return on assets | 3.91% |
| return on equity | 20.7% |
| return on capital employed | 8.64% |
liquidity ratios | |
|---|---|
| current ratio | 1.01 |
| quick ratio | 0.78 |
| cash ratio | 0.28 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 139.38 |
| operating cycle | 210.77 |
| days of payables outstanding | 113.93 |
| cash conversion cycle | 96.84 |
| receivables turnover | 5.11 |
| payables turnover | 3.20 |
| inventory turnover | 2.62 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.42 |
| debt equity ratio | 2.05 |
| long term debt to capitalization | 0.63 |
| total debt to capitalization | 0.67 |
| interest coverage | 2.53 |
| cash flow to debt ratio | 0.10 |
cash flow ratios | |
|---|---|
| free cash flow per share | 1.01 |
| cash per share | 3.24 |
| operating cash flow per share | 1.48 |
| free cash flow operating cash flow ratio | 0.68 |
| cash flow coverage ratios | 0.10 |
| short term coverage ratios | 0.66 |
| capital expenditure coverage ratio | 3.16 |
Frequently Asked Questions
When was the last time Teva Pharmaceutical Industries Limited (NYSE:TEVA) reported earnings?
Teva Pharmaceutical Industries Limited (TEVA) published its most recent earnings results on 31-03-2026.
What is Teva Pharmaceutical Industries Limited's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Teva Pharmaceutical Industries Limited (NYSE:TEVA)'s trailing twelve months ROE is 20.7%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Teva Pharmaceutical Industries Limited (TEVA) currently has a ROA of 3.91%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did TEVA's net profit margin stand at?
TEVA reported a profit margin of 9.02% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is TEVA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.01 in the most recent quarter. The quick ratio stood at 0.78, with a Debt/Eq ratio of 2.05.